Literature DB >> 12647766

Cognitive experimental approaches to investigating impaired cognition in schizophrenia: a paradigm shift.

Angus W MacDonald1, Cameron S Carter.   

Abstract

There has been a growing interest in cognitive deficits in schizophrenia in recent years. The use of traditional clinical neuropsychological measures of cognition in schizophrenia has the advantages of normative data and standardized administration, and remains the standard for cognitive assessment in clinical practice. However for the investigation of cognition in schizophrenia these methods have critical limitations in their ability to measure specific cognitive processes. In this paper we discuss solutions to these interpretive and measurement issues that can be provided by measures derived from experimental cognitive psychology. We suggest that the use of these measures will increasingly become the preferred approach to the investigation of the nature, neurobiology and genetics of impaired cognition in schizophrenia in the coming years.

Entities:  

Mesh:

Year:  2002        PMID: 12647766     DOI: 10.1076/jcen.24.7.873.8386

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  24 in total

1.  Executive function in Parkinson's disease: contributions of the dorsal frontostriatal pathways to action and motivation.

Authors:  Susan M Ravizza; John Goudreau; Mauricio R Delgado; Sandra Ruiz
Journal:  Cogn Affect Behav Neurosci       Date:  2012-03       Impact factor: 3.282

Review 2.  Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes.

Authors:  Beth E Snitz; Angus W Macdonald; Cameron S Carter
Journal:  Schizophr Bull       Date:  2005-09-15       Impact factor: 9.306

3.  Cognitive control in autism spectrum disorders.

Authors:  Marjorie Solomon; Sally J Ozonoff; Neil Cummings; Cameron S Carter
Journal:  Int J Dev Neurosci       Date:  2007-11-13       Impact factor: 2.457

4.  Less unique variance than meets the eye: overlap among traditional neuropsychological dimensions in schizophrenia.

Authors:  Dwight Dickinson; James M Gold
Journal:  Schizophr Bull       Date:  2007-08-16       Impact factor: 9.306

5.  ErbB4 is a suppressor of long-term potentiation in the adult hippocampus.

Authors:  Graham M Pitcher; Simon Beggs; Ran-Sook Woo; Lin Mei; Michael W Salter
Journal:  Neuroreport       Date:  2008-01-22       Impact factor: 1.837

Review 6.  Building a clinically relevant cognitive task: case study of the AX paradigm.

Authors:  Angus W MacDonald
Journal:  Schizophr Bull       Date:  2008-05-16       Impact factor: 9.306

Review 7.  Synapsin III: role in neuronal plasticity and disease.

Authors:  Barbara Porton; William C Wetsel; Hung-Teh Kao
Journal:  Semin Cell Dev Biol       Date:  2011-07-30       Impact factor: 7.727

8.  Evidence of systematic attenuation in the measurement of cognitive deficits in schizophrenia.

Authors:  Michael L Thomas; Virginie M Patt; Andrew Bismark; Joyce Sprock; Melissa Tarasenko; Gregory A Light; Gregory G Brown
Journal:  J Abnorm Psychol       Date:  2017-03-09

9.  Proactive control in adolescents and young adults with autism spectrum disorder: Unimpaired but associated with symptoms of depression.

Authors:  Marie K Krug; Matthew V Elliott; Andrew Gordon; Jeremy Hogeveen; Marjorie Solomon
Journal:  J Abnorm Psychol       Date:  2020-05-14

10.  Context-processing abilities in chronic cocaine users.

Authors:  Jessica A H Jones; Kelvin O Lim; Jeffrey R Wozniak; Sheila Specker; Angus W MacDonald
Journal:  Psychol Addict Behav       Date:  2013-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.